The Week in Review: Deals and Other News

Sino Biopharmaceutical raised $79 million for a single, undisclosed, acquisition; Chindex formed a medical device distribution JV with Fosun Pharma; Charles River Labs defended its $1.6 billion acquisition of WuXi PharmaTech; BioSpectrum released its 2010 Survey of the Asia Pacific life science industry; Kun Run Biotech received SFDA manufacturing approval for a hepatitis B drug; India prohibited the importation of APIs from 10 China companies; China scientists have developed a Helicobacter pylori vaccine; Zhang Jingli, Deputy Director of the SFDA, has been fired; and Hutchison China MediTech jumped 10% on Friday without releasing any news. More details… Stock Symbols: (HK: 1177) (NSDQ: CHDX) (SHA: 600196) (NYSE: CRL) (NYSE: WX) (OTCBB: KURU) (AIM: HCM)